Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.08 trillion and total revenue of $110.13 billion.
Market Cap
1.08T
Revenue
110.13B
Profits
-41.75B
PE Ratio
n/a
Profit Margin
-37.91%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 119.77B | -1.39% | 188,510 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 76.43B | -0.25% | 81,631 | 14.34B |
| 3 | ARGX | argenx SE | 43.46B | -0.94% | 63,064 | 4.25B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.66B | -0.97% | 181,655 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 31.68B | 0.15% | 55,805 | 5.34B |
| 6 | INSM | Insmed Incorporated | 30.00B | -0.26% | 293,625 | 606.42M |
| 7 | RPRX | Royalty Pharma plc | 26.29B | -0.65% | 435,371 | 2.38B |
| 8 | BNTX | BioNTech SE | 21.55B | -0.33% | 528,625 | 3.37B |
| 9 | MRNA | Moderna, Inc. | 20.84B | -1.16% | 1,833,404 | 1.94B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.21B | -1.09% | 511,826 | 13.31M |
| 11 | RVMD | Revolution Medicines, Inc. | 19.00B | 0.85% | 385,170 | - |
| 12 | INCY | Incyte Corporation | 18.33B | 0.10% | 282,620 | 5.14B |
| 13 | GMAB | Genmab A/S | 16.50B | -0.41% | 191,429 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 13.95B | -0.72% | 172,054 | 845.52M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13.20B | 0.18% | 396,507 | 502.08M |
| 16 | SMMT | Summit Therapeutics Inc. | 12.85B | 7.18% | 767,958 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 11.78B | -1.38% | 513,901 | 943.71M |
| 18 | BMRN | BioMarin Pharmaceutical Inc. | 11.25B | -0.96% | 177,091 | 3.22B |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.00B | -0.90% | 196,866 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 10.60B | -0.87% | 368,606 | 2.32B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.09B | 0.30% | 44,166 | 958.40M |
| 22 | ABVX | ABIVAX Société Anonyme | 9.22B | 0.36% | 205,814 | 6.23M |
| 23 | IBRX | ImmunityBio, Inc. | 8.75B | 8.82% | 11,478,825 | 113.29M |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 8.44B | -0.10% | 144,498 | 7.46M |
| 25 | TECH | Bio-Techne Corporation | 7.93B | -1.48% | 597,700 | 1.22B |
| 26 | AXSM | Axsome Therapeutics, Inc. | 7.93B | 0.57% | 98,799 | 638.50M |
| 27 | PCVX | Vaxcyte, Inc. | 7.78B | -3.82% | 285,344 | - |
| 28 | NUVL | Nuvalent, Inc. | 7.72B | 0.16% | 213,540 | - |
| 29 | ARWR | Arrowhead Pharmaceuticals, Inc. | 7.67B | -0.42% | 548,553 | 1.09B |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.54B | 0.50% | 211,847 | 1.40B |
| 31 | KRYS | Krystal Biotech, Inc. | 7.37B | 0.25% | 74,508 | 389.13M |
| 32 | CYTK | Cytokinetics, Incorporated | 7.34B | -0.73% | 468,264 | 88.04M |
| 33 | ACLX | Arcellx, Inc. | 6.71B | 0.10% | 236,825 | 22.29M |
| 34 | BLTE | Belite Bio, Inc | 6.63B | -0.65% | 32,024 | - |
| 35 | KYMR | Kymera Therapeutics, Inc. | 6.53B | 3.17% | 102,017 | 39.21M |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.09B | 0.01% | 141,414 | 46.02M |
| 37 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.00B | -3.64% | 468,836 | 189.76M |
| 38 | COGT | Cogent Biosciences, Inc. | 5.55B | -2.41% | 386,789 | - |
| 39 | MIRM | Mirum Pharmaceuticals, Inc. | 5.47B | 0.92% | 112,232 | 521.31M |
| 40 | PTCT | PTC Therapeutics, Inc. | 5.34B | 1.89% | 163,427 | 1.73B |
| 41 | XENE | Xenon Pharmaceuticals Inc. | 5.33B | -1.74% | 513,689 | 7.50M |
| 42 | CGON | CG Oncology, Inc. | 5.31B | -0.13% | 442,541 | 4.04M |
| 43 | CELC | Celcuity Inc. | 5.25B | 2.36% | 82,118 | - |
| 44 | CAI | Caris Life Sciences, Inc. | 5.12B | 2.46% | 334,275 | 812.03M |
| 45 | IMVT | Immunovant, Inc. | 5.06B | -0.56% | 134,842 | - |
| 46 | APGE | Apogee Therapeutics, Inc. | 5.02B | -0.90% | 132,871 | - |
| 47 | TERN | Terns Pharmaceuticals, Inc. | 4.99B | 3.77% | 1,343,566 | - |
| 48 | SRRK | Scholar Rock Holding Corporation | 4.66B | -2.97% | 203,927 | - |
| 49 | CRSP | CRISPR Therapeutics AG | 4.64B | -1.04% | 518,087 | 3.51M |
| 50 | ERAS | Erasca, Inc. | 4.52B | -0.82% | 1,645,793 | - |
| 51 | FOLD | Amicus Therapeutics, Inc. | 4.51B | 0.03% | 471,496 | 634.21M |
| 52 | VKTX | Viking Therapeutics, Inc. | 4.19B | 2.23% | 970,887 | - |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 4.16B | -1.37% | 55,035 | 268.09M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.10B | -1.39% | 309,479 | 2.04M |
| 55 | TGTX | TG Therapeutics, Inc. | 4.07B | 2.38% | 521,061 | 616.29M |
| 56 | CNTA | Centessa Pharmaceuticals plc | 3.85B | -3.20% | 493,438 | 15.00M |
| 57 | GPCR | Structure Therapeutics Inc. | 3.80B | -1.59% | 128,572 | - |
| 58 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.76B | -1.75% | 96,920 | 7.70M |
| 59 | ACAD | ACADIA Pharmaceuticals Inc. | 3.59B | -0.99% | 247,848 | 1.07B |
| 60 | ADMA | ADMA Biologics, Inc. | 3.57B | -0.13% | 639,578 | 510.17M |
| 61 | LEGN | Legend Biotech Corporation | 3.45B | -2.10% | 368,267 | 1.03B |
| 62 | CORT | Corcept Therapeutics Incorporated | 3.43B | -0.37% | 131,637 | 761.41M |
| 63 | NAMS | NewAmsterdam Pharma Company N.V. | 3.37B | -1.61% | 86,147 | 22.50M |
| 64 | DNLI | Denali Therapeutics Inc. | 3.22B | -1.98% | 153,406 | - |
| 65 | SYRE | Spyre Therapeutics, Inc. | 3.22B | 1.31% | 126,905 | - |
| 66 | EWTX | Edgewise Therapeutics, Inc. | 3.17B | -1.40% | 131,242 | - |
| 67 | ALMS | Alumis Inc. | 3.11B | -0.48% | 329,053 | 22.12M |
| 68 | VRDN | Viridian Therapeutics, Inc. | 3.00B | 3.17% | 317,216 | 70.85M |
| 69 | DYN | Dyne Therapeutics, Inc. | 2.93B | -1.61% | 513,855 | - |
| 70 | TARS | Tarsus Pharmaceuticals, Inc. | 2.91B | 0.36% | 63,895 | 451.36M |
| 71 | VERA | Vera Therapeutics, Inc. | 2.89B | -1.68% | 308,418 | - |
| 72 | ARQT | Arcutis Biotherapeutics, Inc. | 2.87B | 0.83% | 239,876 | 376.07M |
| 73 | IDYA | IDEAYA Biosciences, Inc. | 2.85B | -1.07% | 91,979 | 218.71M |
| 74 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.81B | -1.67% | 266,271 | 588.99M |
| 75 | RCUS | Arcus Biosciences, Inc. | 2.72B | -4.27% | 173,507 | 247.00M |
| 76 | TLX | Telix Pharmaceuticals Limited | 2.71B | - | 57,756 | 803.79M |
| 77 | TVTX | Travere Therapeutics, Inc. | 2.54B | 0.07% | 147,356 | 490.73M |
| 78 | BEAM | Beam Therapeutics Inc. | 2.49B | -1.99% | 381,541 | 139.74M |
| 79 | TNGX | Tango Therapeutics, Inc. | 2.43B | -0.64% | 646,837 | 62.38M |
| 80 | WVE | Wave Life Sciences Ltd. | 2.42B | -3.52% | 553,436 | 42.73M |
| 81 | APLS | Apellis Pharmaceuticals, Inc. | 2.40B | 1.98% | 251,950 | 1.00B |
| 82 | MAZE | Maze Therapeutics, Inc. | 2.39B | -4.04% | 137,697 | 2.50M |
| 83 | IMNM | Immunome, Inc. | 2.34B | -1.48% | 188,894 | 6.94M |
| 84 | IRON | Disc Medicine, Inc. | 2.29B | 0.38% | 66,657 | - |
| 85 | DAWN | Day One Biopharmaceuticals, Inc. | 2.20B | 0.05% | 1,629,547 | 158.18M |
| 86 | AAPG | Ascentage Pharma Group International | 2.14B | -4.17% | 675 | 54.52M |
| 87 | MLYS | Mineralys Therapeutics, Inc. | 2.13B | -0.41% | 260,195 | - |
| 88 | GLPG | Galapagos NV | 2.11B | 1.06% | 56,415 | 1.31B |
| 89 | RARE | Ultragenyx Pharmaceutical Inc. | 2.09B | -0.09% | 474,681 | 673.00M |
| 90 | ZLAB | Zai Lab Limited | 2.07B | -2.12% | 128,100 | 460.16M |
| 91 | SNDX | Syndax Pharmaceuticals, Inc. | 2.07B | -2.38% | 568,124 | 172.35M |
| 92 | NKTR | Nektar Therapeutics | 2.00B | 1.76% | 621,972 | 55.23M |
| 93 | STOK | Stoke Therapeutics, Inc. | 1.99B | -4.36% | 113,649 | 205.63M |
| 94 | CLDX | Celldex Therapeutics, Inc. | 1.99B | - | 151,883 | 1.55M |
| 95 | MANE | Veradermics, Incorporated | 1.99B | 3.10% | 52,875 | - |
| 96 | ADPT | Adaptive Biotechnologies Corporation | 1.97B | 2.65% | 846,457 | 276.98M |
| 97 | MESO | Mesoblast Limited | 1.93B | -1.53% | 82,892 | 65.38M |
| 98 | RLAY | Relay Therapeutics, Inc. | 1.89B | 0.19% | 572,049 | 15.36M |
| 99 | ANAB | AnaptysBio, Inc. | 1.88B | 2.30% | 159,885 | 234.60M |
| 100 | OCUL | Ocular Therapeutix, Inc. | 1.87B | -2.93% | 923,090 | 51.95M |
| 101 | TYRA | Tyra Biosciences, Inc. | 1.86B | -3.83% | 175,674 | - |
| 102 | AUPH | Aurinia Pharmaceuticals Inc. | 1.86B | -2.44% | 169,305 | 283.06M |
| 103 | ORKA | Oruka Therapeutics, Inc. | 1.85B | 16.63% | 401,915 | - |
| 104 | RXRX | Recursion Pharmaceuticals, Inc. | 1.79B | 2.74% | 7,253,511 | 74.68M |
| 105 | PVLA | Palvella Therapeutics, Inc. | 1.77B | -3.30% | 89,075 | - |
| 106 | SRPT | Sarepta Therapeutics, Inc. | 1.77B | -0.88% | 537,980 | 2.20B |
| 107 | SLNO | Soleno Therapeutics, Inc. | 1.77B | -6.61% | 773,961 | 190.41M |
| 108 | DFTX | Definium Therapeutics, Inc. | 1.76B | -1.78% | 215,202 | - |
| 109 | GENB | Generate Biomedicines, Inc. | 1.71B | 1.28% | 185,918 | 31.89M |
| 110 | ELVN | Enliven Therapeutics, Inc. | 1.71B | -0.62% | 146,564 | - |
| 111 | ZYME | Zymeworks Inc. | 1.69B | -1.33% | 159,667 | 105.97M |
| 112 | NVAX | Novavax, Inc. | 1.68B | 0.34% | 752,768 | 1.12B |
| 113 | PHVS | Pharvaris N.V. | 1.68B | -2.18% | 20,875 | - |
| 114 | SION | Sionna Therapeutics, Inc. | 1.65B | 0.22% | 69,242 | - |
| 115 | AGIO | Agios Pharmaceuticals, Inc. | 1.61B | -0.40% | 117,410 | 54.03M |
| 116 | INVA | Innoviva, Inc. | 1.61B | -1.27% | 92,834 | 411.33M |
| 117 | IOVA | Iovance Biotherapeutics, Inc. | 1.60B | -4.42% | 6,991,153 | 263.50M |
| 118 | HRMY | Harmony Biosciences Holdings, Inc. | 1.60B | -0.68% | 90,143 | 868.45M |
| 119 | VCEL | Vericel Corporation | 1.59B | -2.74% | 139,329 | 276.26M |
| 120 | CAPR | Capricor Therapeutics, Inc. | 1.58B | -8.59% | 768,100 | 11.13M |
| 121 | OCS | Oculis Holding AG | 1.57B | -2.20% | 121,182 | 1.51M |
| 122 | IMCR | Immunocore Holdings plc | 1.57B | -0.42% | 54,128 | 400.02M |
| 123 | NRIX | Nurix Therapeutics, Inc. | 1.56B | -2.75% | 110,108 | 83.98M |
| 124 | NBTX | Nanobiotix S.A. | 1.53B | 8.03% | 37,214 | 11.93M |
| 125 | BHVN | Biohaven Ltd. | 1.53B | 2.62% | 336,529 | - |
| 126 | NTLA | Intellia Therapeutics, Inc. | 1.52B | 0.31% | 711,503 | 67.67M |
| 127 | NUVB | Nuvation Bio Inc. | 1.52B | 1.60% | 959,862 | 62.90M |
| 128 | VIR | Vir Biotechnology, Inc. | 1.47B | -2.74% | 709,140 | 68.56M |
| 129 | KOD | Kodiak Sciences Inc. | 1.46B | -1.28% | 75,958 | - |
| 130 | TRVI | Trevi Therapeutics, Inc. | 1.43B | -0.18% | 198,304 | - |
| 131 | ARDX | Ardelyx, Inc. | 1.42B | 2.65% | 664,549 | 407.32M |
| 132 | ATAI | AtaiBeckley Inc. | 1.38B | -1.18% | 1,233,312 | 4.09M |
| 133 | RAPP | Rapport Therapeutics, Inc. | 1.34B | -2.16% | 108,966 | - |
| 134 | MBX | MBX Biosciences, Inc. | 1.33B | 0.43% | 143,222 | - |
| 135 | SVRA | Savara Inc. | 1.32B | 0.28% | 252,881 | - |
| 136 | ZBIO | Zenas BioPharma, Inc. | 1.30B | -1.02% | 50,409 | 15.00M |
| 137 | GLUE | Monte Rosa Therapeutics, Inc. | 1.29B | 1.68% | 277,879 | 181.54M |
| 138 | CRVS | Corvus Pharmaceuticals, Inc. | 1.28B | -4.56% | 256,526 | - |
| 139 | IMTX | Immatics N.V. | 1.27B | 0.85% | 74,893 | 56.67M |
| 140 | MLTX | MoonLake Immunotherapeutics | 1.26B | 3.11% | 131,832 | - |
| 141 | TSHA | Taysha Gene Therapies, Inc. | 1.24B | -2.17% | 388,174 | 6.31M |
| 142 | PGEN | Precigen, Inc. | 1.23B | 6.10% | 584,716 | 6.31M |
| 143 | BCAX | Bicara Therapeutics Inc. | 1.23B | -1.51% | 43,588 | - |
| 144 | ORIC | ORIC Pharmaceuticals, Inc. | 1.18B | - | 274,468 | - |
| 145 | IVA | Inventiva S.A. | 1.17B | -2.27% | 55,231 | 19.93M |
| 146 | SEPN | Septerna, Inc. | 1.16B | -2.36% | 39,935 | 45.95M |
| 147 | OLMA | Olema Pharmaceuticals, Inc. | 1.15B | -1.88% | 273,543 | - |
| 148 | DBVT | DBV Technologies S.A. | 1.13B | 1.45% | 153,659 | 5.50M |
| 149 | EYPT | EyePoint, Inc. | 1.10B | -5.99% | 342,117 | 31.37M |
| 150 | AVBP | ArriVent BioPharma, Inc. | 1.08B | 1.72% | 85,147 | - |
| 151 | ABCL | AbCellera Biologics Inc. | 1.07B | 1.30% | 719,026 | 75.13M |
| 152 | PHAR | Pharming Group N.V. | 1.05B | -0.59% | 13,584 | 376.13M |
| 153 | GERN | Geron Corporation | 1.02B | -0.94% | 2,793,554 | 183.88M |
| 154 | INBX | Inhibrx Biosciences, Inc. | 1.00B | -0.36% | 24,115 | 1.40M |
| 155 | QURE | uniQure N.V. | 999.22M | -5.67% | 640,937 | 16.10M |
| 156 | AKTS | Aktis Oncology, Inc. | 992.67M | 3.34% | 86,792 | 5.56M |
| 157 | XERS | Xeris Biopharma Holdings, Inc. | 945.79M | 0.09% | 349,888 | 291.85M |
| 158 | GHRS | GH Research PLC | 942.85M | -2.06% | 29,881 | - |
| 159 | CMPX | Compass Therapeutics, Inc. | 932.86M | -0.19% | 194,130 | 850.00K |
| 160 | SLS | SELLAS Life Sciences Group, Inc. | 925.48M | 8.05% | 2,832,291 | - |
| 161 | VALN | Valneva SE | 902.92M | 0.71% | 4,577 | 211.09M |
| 162 | SGP | SpyGlass Pharma, Inc. | 892.91M | 1.44% | 27,746 | - |
| 163 | URGN | UroGen Pharma Ltd. | 880.18M | -3.78% | 143,138 | 109.79M |
| 164 | SANA | Sana Biotechnology, Inc. | 876.66M | 6.31% | 1,839,678 | - |
| 165 | KALV | KalVista Pharmaceuticals, Inc. | 873.44M | -0.58% | 83,115 | 1.43M |
| 166 | XNCR | Xencor, Inc. | 861.73M | 1.21% | 181,973 | 125.58M |
| 167 | ANNX | Annexon, Inc. | 846.64M | 4.41% | 470,115 | - |
| 168 | MNKD | MannKind Corporation | 842.65M | -3.01% | 751,713 | 348.97M |
| 169 | MPLT | MapLight Therapeutics, Inc. | 841.84M | 0.78% | 36,045 | - |
| 170 | MRVI | Maravai LifeSciences Holdings, Inc. | 839.32M | -0.76% | 141,997 | 185.74M |
| 171 | JANX | Janux Therapeutics, Inc. | 838.26M | -1.18% | 175,698 | 10.00M |
| 172 | OCGN | Ocugen, Inc. | 834.50M | 8.76% | 8,405,800 | 4.41M |
| 173 | FTRE | Fortrea Holdings Inc. | 831.22M | -1.66% | 268,908 | 2.72B |
| 174 | CGEM | Cullinan Therapeutics, Inc. | 823.16M | -2.51% | 127,486 | - |
| 175 | SPRY | ARS Pharmaceuticals, Inc. | 821.19M | 0.36% | 258,203 | 84.28M |
| 176 | ABUS | Arbutus Biopharma Corporation | 819.30M | -1.39% | 330,565 | 14.61M |
| 177 | CTMX | CytomX Therapeutics, Inc. | 816.68M | -1.03% | 432,156 | 113.63M |
| 178 | OMER | Omeros Corporation | 803.30M | -0.79% | 140,937 | - |
| 179 | PHAT | Phathom Pharmaceuticals, Inc. | 795.08M | -1.27% | 310,006 | 175.11M |
| 180 | EVMN | Evommune, Inc. | 780.88M | -5.66% | 52,858 | 13.00M |
| 181 | ARVN | Arvinas, Inc. | 775.85M | -2.80% | 159,110 | 262.60M |
| 182 | KURA | Kura Oncology, Inc. | 775.54M | -0.68% | 371,965 | 67.48M |
| 183 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 730.70M | - | 54,393 | - |
| 184 | TENX | Tenax Therapeutics, Inc. | 724.33M | 1.48% | 90,712 | - |
| 185 | LXRX | Lexicon Pharmaceuticals, Inc. | 718.14M | -1.45% | 967,449 | 49.80M |
| 186 | ANRO | Alto Neuroscience, Inc. | 707.07M | 2.38% | 133,994 | - |
| 187 | DRUG | Bright Minds Biosciences Inc. | 702.88M | 3.03% | 24,337 | - |
| 188 | GYRE | Gyre Therapeutics, Inc. | 699.86M | -1.35% | 71,297 | 116.59M |
| 189 | TBPH | Theravance Biopharma, Inc. | 691.17M | -1.80% | 77,442 | 80.33M |
| 190 | JBIO | Jade Biosciences, Inc. | 686.48M | 0.43% | 33,946 | - |
| 191 | AGMB | AgomAb Therapeutics NV | 682.31M | 0.65% | 2,681 | - |
| 192 | PROK | ProKidney Corp. | 676.88M | 0.45% | 228,899 | 744.00K |
| 193 | LBRX | LB Pharmaceuticals Inc | 668.28M | 5.91% | 80,890 | - |
| 194 | PRME | Prime Medicine, Inc. | 654.31M | -0.94% | 616,320 | 4.63M |
| 195 | MDXG | MiMedx Group, Inc. | 650.72M | - | 149,023 | 418.63M |
| 196 | EIKN | Eikon Therapeutics, Inc. | 629.73M | -0.98% | 169,833 | - |
| 197 | DRTS | Alpha Tau Medical Ltd. | 616.07M | 0.43% | 52,354 | - |
| 198 | ZURA | Zura Bio Limited | 614.32M | -4.64% | 85,005 | - |
| 199 | DSGN | Design Therapeutics, Inc. | 611.79M | -1.00% | 28,967 | - |
| 200 | MGTX | MeiraGTx Holdings plc | 608.51M | -1.05% | 27,827 | 27.42M |
| 201 | ZVRA | Zevra Therapeutics, Inc. | 604.73M | 1.13% | 180,367 | 106.47M |
| 202 | REPL | Replimune Group, Inc. | 604.43M | -3.43% | 248,680 | - |
| 203 | TECX | Tectonic Therapeutic, Inc. | 602.64M | -5.93% | 51,227 | - |
| 204 | SLDB | Solid Biosciences Inc. | 585.11M | -2.59% | 315,494 | - |
| 205 | VOR | Vor Biopharma Inc. | 581.28M | -0.36% | 176,182 | - |
| 206 | ALLO | Allogene Therapeutics, Inc. | 550.59M | -0.81% | 1,506,351 | 22.00K |
| 207 | ADCT | ADC Therapeutics SA | 539.94M | -2.30% | 173,426 | 81.36M |
| 208 | NMRA | Neumora Therapeutics, Inc. | 530.21M | -0.64% | 137,270 | - |
| 209 | IMMX | Immix Biopharma, Inc. | 525.90M | -1.29% | 153,983 | - |
| 210 | VNDA | Vanda Pharmaceuticals Inc. | 525.47M | -4.31% | 402,070 | 216.11M |
| 211 | YDES | YD Bio Limited | 523.88M | -0.80% | 2,254 | 510.36K |
| 212 | RCKT | Rocket Pharmaceuticals, Inc. | 521.13M | -2.44% | 423,589 | - |
| 213 | CTNM | Contineum Therapeutics, Inc. | 516.36M | -0.22% | 30,468 | - |
| 214 | VSTM | Verastem, Inc. | 514.71M | 0.34% | 365,220 | 30.91M |
| 215 | IVVD | Invivyd, Inc. | 514.32M | 1.11% | 223,838 | 53.43M |
| 216 | KYTX | Kyverna Therapeutics, Inc. | 514.17M | 2.62% | 170,278 | - |
| 217 | LRMR | Larimar Therapeutics, Inc. | 503.86M | -2.73% | 1,526,252 | - |
| 218 | UPB | Upstream Bio, Inc. | 503.64M | -1.22% | 172,406 | 2.80M |
| 219 | FULC | Fulcrum Therapeutics, Inc. | 502.83M | -1.05% | 80,826 | 80.00M |
| 220 | CRMD | CorMedix Inc. | 498.02M | -1.56% | 328,323 | 311.71M |
| 221 | FBRX | Forte Biosciences, Inc. | 491.61M | 1.66% | 19,151 | - |
| 222 | PRTA | Prothena Corporation plc | 491.50M | -1.93% | 68,900 | 9.68M |
| 223 | RIGL | Rigel Pharmaceuticals, Inc. | 486.58M | -0.98% | 43,037 | 294.28M |
| 224 | ACRS | Aclaris Therapeutics, Inc. | 486.48M | -0.28% | 151,420 | 7.83M |
| 225 | LXEO | Lexeo Therapeutics, Inc. | 484.64M | 0.15% | 303,972 | - |
| 226 | ENGN | enGene Holdings Inc. | 479.98M | -1.85% | 221,951 | - |
| 227 | AVIR | Atea Pharmaceuticals, Inc. | 477.24M | -1.80% | 125,973 | - |
| 228 | LYEL | Lyell Immunopharma, Inc. | 467.37M | -11.20% | 34,569 | 36.00K |
| 229 | ALT | Altimmune, Inc. | 463.05M | -1.11% | 482,785 | 41.00K |
| 230 | TRDA | Entrada Therapeutics, Inc. | 461.16M | -1.31% | 26,331 | 25.42M |
| 231 | RGNX | REGENXBIO Inc. | 451.10M | -3.74% | 178,864 | 170.44M |
| 232 | EPRX | Eupraxia Pharmaceuticals Inc. | 450.65M | -1.20% | 30,848 | - |
| 233 | ASMB | Assembly Biosciences, Inc. | 448.89M | 0.28% | 12,972 | 37.19M |
| 234 | RLMD | Relmada Therapeutics, Inc. | 441.47M | -2.11% | 258,562 | - |
| 235 | AVXL | Anavex Life Sciences Corp. | 439.73M | 2.04% | 254,330 | - |
| 236 | FDMT | 4D Molecular Therapeutics, Inc. | 434.08M | 0.71% | 123,330 | 120.00K |
| 237 | IPSC | Century Therapeutics, Inc. | 424.15M | -5.60% | 415,153 | 109.16M |
| 238 | STTK | Shattuck Labs, Inc. | 420.80M | -4.08% | 79,213 | 1.00M |
| 239 | VTVT | vTv Therapeutics Inc. | 416.15M | -0.52% | 49,191 | 17.00K |
| 240 | PEPG | PepGen Inc. | 411.93M | -3.09% | 225,758 | - |
| 241 | LCTX | Lineage Cell Therapeutics, Inc. | 410.99M | 4.43% | 630,823 | 14.56M |
| 242 | DNA | Ginkgo Bioworks Holdings, Inc. | 401.05M | 7.66% | 581,466 | 170.16M |
| 243 | STRO | Sutro Biopharma, Inc. | 399.62M | -0.27% | 18,269 | 105.65M |
| 244 | PRTC | PureTech Health plc | 397.78M | -0.75% | 630 | 6.39M |
| 245 | ARMP | Armata Pharmaceuticals, Inc. | 396.84M | 2.54% | 6,631 | 5.05M |
| 246 | MNPR | Monopar Therapeutics Inc. | 395.54M | 2.76% | 139,968 | - |
| 247 | BNTC | Benitec Biopharma Inc. | 393.93M | -5.12% | 16,293 | - |
| 248 | CBIO | Crescent Biopharma, Inc. | 393.92M | 2.60% | 51,637 | 10.84M |
| 249 | NAGE | Niagen Bioscience, Inc. | 386.79M | - | 256,920 | 129.42M |
| 250 | AUTL | Autolus Therapeutics plc | 385.91M | -0.68% | 363,122 | 51.13M |
| 251 | ENTA | Enanta Pharmaceuticals, Inc. | 385.09M | -1.04% | 16,944 | 66.98M |
| 252 | LENZ | LENZ Therapeutics, Inc. | 382.99M | 3.55% | 171,992 | 17.50M |
| 253 | DMAC | DiaMedica Therapeutics Inc. | 376.66M | -2.90% | 58,207 | - |
| 254 | AURA | Aura Biosciences, Inc. | 375.30M | -0.67% | 132,526 | - |
| 255 | GLSI | Greenwich LifeSciences, Inc. | 367.56M | -0.04% | 78,413 | - |
| 256 | ABSI | Absci Corporation | 362.40M | 4.78% | 814,419 | 2.82M |
| 257 | CADL | Candel Therapeutics, Inc. | 357.45M | -2.01% | 436,702 | - |
| 258 | IRD | Opus Genetics, Inc. | 349.47M | 3.31% | 476,979 | 14.20M |
| 259 | XFOR | X4 Pharmaceuticals, Inc. | 348.00M | 2.58% | 61,218 | 33.98M |
| 260 | BCYC | Bicycle Therapeutics plc | 344.06M | -1.59% | 69,113 | 28.34M |
| 261 | NBP | NovaBridge Biosciences | 336.65M | -0.68% | 189,490 | - |
| 262 | NERV | Minerva Neurosciences, Inc. | 336.46M | 1.11% | 73,409 | - |
| 263 | CLYM | Climb Bio, Inc. | 335.81M | -3.17% | 39,667 | - |
| 264 | XOMA | XOMA Royalty Corporation | 319.44M | 0.04% | 15,497 | 47.11M |
| 265 | IMRX | Immuneering Corporation | 318.74M | -9.54% | 777,120 | - |
| 266 | SLN | Silence Therapeutics plc | 318.36M | -3.30% | 35,336 | 559.00K |
| 267 | NGNE | Neurogene Inc. | 315.99M | -8.52% | 58,759 | 925.00K |
| 268 | AVTX | Avalo Therapeutics, Inc. | 306.94M | -0.78% | 101,720 | 192.00K |
| 269 | ANL | Adlai Nortye Ltd. | 306.64M | -0.60% | 26,937 | -1.35M |
| 270 | RZLT | Rezolute, Inc. | 303.83M | -3.15% | 322,989 | - |
| 271 | PBYI | Puma Biotechnology, Inc. | 299.66M | 0.17% | 54,645 | 228.37M |
| 272 | ACIU | AC Immune SA | 299.30M | 0.83% | 122,279 | 5.48M |
| 273 | FHTX | Foghorn Therapeutics Inc. | 297.61M | 3.05% | 55,630 | 30.91M |
| 274 | CABA | Cabaletta Bio, Inc. | 297.46M | -3.13% | 565,702 | - |
| 275 | PALI | Palisade Bio, Inc. | 295.03M | -2.46% | 1,223,809 | - |
| 276 | NAUT | Nautilus Biotechnology, Inc. | 293.63M | 1.31% | 78,531 | - |
| 277 | CNTX | Context Therapeutics Inc. | 292.18M | 2.91% | 527,272 | - |
| 278 | TARA | Protara Therapeutics, Inc. | 286.11M | -0.56% | 99,382 | - |
| 279 | CCCC | C4 Therapeutics, Inc. | 278.10M | 3.64% | 844,560 | 35.95M |
| 280 | VYGR | Voyager Therapeutics, Inc. | 276.24M | -4.83% | 214,729 | 40.37M |
| 281 | PLYX | Polaryx Therapeutics, Inc. | 271.28M | 23.23% | 1,182,953 | - |
| 282 | CBUS | Cibus, Inc. | 270.23M | 2.30% | 82,990 | 3.79M |
| 283 | OABI | OmniAb, Inc. | 268.57M | 0.27% | 41,380 | 18.67M |
| 284 | CAMP | Camp4 Therapeutics Corporation | 267.90M | -4.09% | 16,586 | 3.50M |
| 285 | CLLS | Cellectis S.A. | 265.96M | 7.21% | 16,196 | 82.55M |
| 286 | PRLD | Prelude Therapeutics Incorporated | 265.32M | -4.45% | 107,705 | 12.14M |
| 287 | OVID | Ovid Therapeutics Inc. | 264.93M | 1.24% | 309,207 | 6.61M |
| 288 | ABEO | Abeona Therapeutics Inc. | 264.18M | -1.61% | 266,521 | 400.00K |
| 289 | ALXO | ALX Oncology Holdings Inc. | 261.90M | -1.49% | 143,614 | - |
| 290 | ALDX | Aldeyra Therapeutics, Inc. | 261.80M | -6.85% | 1,387,587 | - |
| 291 | SLGL | Sol-Gel Technologies Ltd. | 260.47M | 9.60% | 12,557 | 18.97M |
| 292 | FENC | Fennec Pharmaceuticals Inc. | 260.42M | -0.07% | 15,004 | 38.79M |
| 293 | ENLV | Enlivex Ltd. | 258.75M | 1.87% | 35,657 | - |
| 294 | HELP | Cybin Inc. | 256.68M | - | 197,359 | - |
| 295 | IKT | Inhibikase Therapeutics, Inc. | 255.10M | -6.28% | 216,707 | 1.00 |
| 296 | CHRS | Coherus Oncology, Inc. | 252.56M | -0.30% | 298,847 | 42.17M |
| 297 | EDIT | Editas Medicine, Inc. | 246.64M | -0.79% | 362,476 | 40.52M |
| 298 | OBIO | Orchestra BioMed Holdings, Inc. | 246.19M | -0.46% | 30,570 | 33.48M |
| 299 | ALEC | Alector, Inc. | 245.00M | -0.45% | 123,385 | 21.05M |
| 300 | NVCT | Nuvectis Pharma, Inc. | 241.34M | 1.00% | 4,576 | - |
| 301 | SRZN | Surrozen, Inc. | 233.07M | -3.47% | 99,226 | 3.60M |
| 302 | HUMA | Humacyte, Inc. | 228.70M | 3.95% | 903,230 | 1.57M |
| 303 | PLX | Protalix BioTherapeutics, Inc. | 228.40M | 1.79% | 259,804 | 61.84M |
| 304 | CGEN | Compugen Ltd. | 221.26M | 5.88% | 100,792 | 72.76M |
| 305 | KROS | Keros Therapeutics, Inc. | 221.03M | 2.00% | 72,271 | 244.06M |
| 306 | CNTN | Canton Strategic Holdings, Inc. | 219.98M | 1.79% | 246,530 | - |
| 307 | SABS | SAB Biotherapeutics, Inc. | 219.09M | -6.32% | 200,127 | 114.70K |
| 308 | ELDN | Eledon Pharmaceuticals, Inc. | 219.01M | 1.47% | 239,904 | - |
| 309 | ACHV | Achieve Life Sciences, Inc. | 218.26M | -0.97% | 132,455 | - |
| 310 | MDWD | MediWound Ltd. | 215.87M | 1.36% | 5,283 | 16.96M |
| 311 | RNAC | Cartesian Therapeutics, Inc. | 212.07M | -1.48% | 54,775 | 2.80M |
| 312 | ELTX | Elicio Therapeutics, Inc. | 203.41M | 6.79% | 51,358 | - |
| 313 | GALT | Galectin Therapeutics Inc. | 201.16M | -1.27% | 40,705 | - |
| 314 | ARCT | Arcturus Therapeutics Holdings Inc. | 198.11M | -0.43% | 93,678 | 82.03M |
| 315 | MGNX | MacroGenics, Inc. | 197.66M | -0.32% | 432,453 | 149.50M |
| 316 | ABOS | Acumen Pharmaceuticals, Inc. | 196.26M | -1.82% | 86,596 | - |
| 317 | PRQR | ProQR Therapeutics N.V. | 188.04M | 3.78% | 260,332 | 19.19M |
| 318 | KRRO | Korro Bio, Inc. | 187.78M | 13.22% | 432,011 | 6.39M |
| 319 | WHWK | Whitehawk Therapeutics, Inc. | 186.16M | 1.28% | 26,716 | 7.15M |
| 320 | CRBU | Caribou Biosciences, Inc. | 183.61M | 0.53% | 300,091 | 11.16M |
| 321 | TNYA | Tenaya Therapeutics, Inc. | 182.60M | -5.76% | 1,477,953 | - |
| 322 | ADAG | Adagene Inc. | 180.51M | 7.58% | 88,604 | 103.20K |
| 323 | MOLN | Molecular Partners AG | 179.76M | -4.56% | 1,066 | 856.30K |
| 324 | ZNTL | Zentalis Pharmaceuticals, Inc. | 179.68M | 0.91% | 127,547 | 26.87M |
| 325 | TNXP | Tonix Pharmaceuticals Holding Corp. | 177.20M | 3.28% | 201,864 | 13.11M |
| 326 | PMN | ProMIS Neurosciences, Inc. | 177.11M | -1.00% | 13,781 | - |
| 327 | MIST | Milestone Pharmaceuticals Inc. | 172.18M | -3.14% | 189,078 | - |
| 328 | HRTX | Heron Therapeutics, Inc. | 172.13M | -1.61% | 491,481 | 154.90M |
| 329 | NTHI | NeOnc Technologies Holdings, Inc. | 171.84M | -3.94% | 48,458 | 59.99K |
| 330 | VXRT | Vaxart, Inc. | 170.49M | -3.66% | 308,629 | 237.26M |
| 331 | KLRS | Kalaris Therapeutics, Inc. | 169.44M | -1.20% | 5,658 | - |
| 332 | SGMT | Sagimet Biosciences Inc. | 169.44M | -2.62% | 123,851 | - |
| 333 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 169.21M | -0.52% | 27,336 | - |
| 334 | IMUX | Immunic, Inc. | 163.08M | -8.76% | 2,036,175 | - |
| 335 | CNTB | Connect Biopharma Holdings Limited | 162.12M | 3.57% | 26,280 | 762.00K |
| 336 | NKTX | Nkarta, Inc. | 160.88M | -1.09% | 106,847 | - |
| 337 | RANI | Rani Therapeutics Holdings, Inc. | 159.80M | 1.94% | 130,208 | 1.20M |
| 338 | TLSA | Tiziana Life Sciences Ltd | 158.25M | -1.59% | 38,954 | - |
| 339 | MENS | Jyong Biotech Ltd. | 157.65M | -4.65% | 65,251 | - |
| 340 | CDXS | Codexis, Inc. | 155.81M | 0.88% | 3,338,575 | 70.39M |
| 341 | ARTV | Artiva Biotherapeutics, Inc. | 151.02M | -9.48% | 90,284 | 251.00K |
| 342 | EQ | Equillium, Inc. | 149.19M | 18.36% | 1,455,592 | 4.39M |
| 343 | UNCY | Unicycive Therapeutics, Inc. | 147.22M | -2.28% | 147,093 | - |
| 344 | SPRO | Spero Therapeutics, Inc. | 145.81M | -0.07% | 38,423 | 40.55M |
| 345 | SGMO | Sangamo Therapeutics, Inc. | 145.18M | -1.39% | 1,033,227 | 32.88M |
| 346 | ORMP | Oramed Pharmaceuticals Inc. | 139.71M | 3.85% | 82,500 | 2.00M |
| 347 | IPHA | Innate Pharma S.A. | 137.43M | - | 16,068 | 14.84M |
| 348 | ANTX | AN2 Therapeutics, Inc. | 137.01M | -8.09% | 157,727 | - |
| 349 | KPTI | Karyopharm Therapeutics Inc. | 136.11M | -6.08% | 311,962 | 146.07M |
| 350 | FATE | Fate Therapeutics, Inc. | 134.28M | -1.28% | 279,312 | 6.65M |
| 351 | DTIL | Precision BioSciences, Inc. | 133.24M | -2.38% | 120,465 | 34.26M |
| 352 | CRDF | Cardiff Oncology, Inc. | 128.53M | -1.57% | 114,646 | 593.00K |
| 353 | ACOG | Alpha Cognition Inc. | 128.28M | 0.85% | 2,616 | 7.43M |
| 354 | HURA | TuHURA Biosciences, Inc. | 126.30M | 6.12% | 265,846 | - |
| 355 | BDTX | Black Diamond Therapeutics, Inc. | 124.78M | 2.82% | 247,492 | 70.00M |
| 356 | INO | Inovio Pharmaceuticals, Inc. | 115.42M | - | 460,651 | 65.34K |
| 357 | GNLX | Genelux Corporation | 112.26M | -3.61% | 33,972 | 8.00K |
| 358 | AARD | Aardvark Therapeutics, Inc. | 111.04M | -3.04% | 54,343 | - |
| 359 | TTRX | Turn Therapeutics Inc. | 109.68M | - | 302 | - |
| 360 | COYA | Coya Therapeutics, Inc. | 109.50M | -1.68% | 45,212 | 3.99M |
| 361 | VRCA | Verrica Pharmaceuticals Inc. | 105.65M | - | 12,455 | 35.58M |
| 362 | QTTB | Q32 Bio Inc. | 105.48M | 2.41% | 201,752 | 53.74M |
| 363 | AGEN | Agenus Inc. | 105.43M | 4.03% | 136,319 | 106.83M |
| 364 | GOSS | Gossamer Bio, Inc. | 104.90M | -1.48% | 1,480,404 | 44.05M |
| 365 | GANX | Gain Therapeutics, Inc. | 103.27M | -2.36% | 258,153 | - |
| 366 | ONCY | Oncolytics Biotech Inc. | 103.16M | -0.29% | 245,512 | - |
| 367 | DWTX | Dogwood Therapeutics, Inc. | 100.89M | 0.66% | 14,274 | - |
| 368 | SEER | Seer, Inc. | 100.43M | -2.73% | 14,810 | 16.58M |
| 369 | FBIO | Fortress Biotech, Inc. | 98.70M | -3.05% | 182,436 | 62.30M |
| 370 | PYXS | Pyxis Oncology, Inc. | 96.51M | 1.31% | 86,978 | 2.82M |
| 371 | ANIX | Anixa Biosciences, Inc. | 95.89M | - | 9,755 | - |
| 372 | BMEA | Biomea Fusion, Inc. | 95.45M | -4.26% | 210,119 | - |
| 373 | CGTX | Cognition Therapeutics, Inc. | 95.34M | - | 90,130 | - |
| 374 | CING | Cingulate Inc. | 91.37M | -3.84% | 317,969 | - |
| 375 | VANI | Vivani Medical, Inc. | 88.64M | - | 24,727 | - |
| 376 | IBIO | iBio, Inc. | 88.60M | 3.01% | 438,038 | 300.00K |
| 377 | MAIA | MAIA Biotechnology, Inc. | 88.58M | -3.82% | 242,089 | - |
| 378 | OKYO | OKYO Pharma Limited | 86.30M | -1.18% | 3,214 | - |
| 379 | ATYR | aTyr Pharma, Inc. | 83.78M | -1.50% | 155,816 | 190.00K |
| 380 | PMVP | PMV Pharmaceuticals, Inc. | 83.73M | -0.63% | 113,904 | - |
| 381 | SPRB | Spruce Biosciences, Inc. | 83.39M | 1.47% | 2,212 | 697.00K |
| 382 | KZIA | Kazia Therapeutics Limited | 82.70M | -5.24% | 18,520 | 1.20M |
| 383 | PLRX | Pliant Therapeutics, Inc. | 82.34M | -4.96% | 236,253 | - |
| 384 | PYPD | PolyPid Ltd. | 80.91M | 1.68% | 22,001 | - |
| 385 | PTHS | Pelthos Therapeutics Inc. | 80.08M | 6.45% | 8,809 | 7.41M |
| 386 | CSBR | Champions Oncology, Inc. | 79.71M | - | 4,543 | 58.42M |
| 387 | MCRB | Seres Therapeutics, Inc. | 78.89M | -3.65% | 4,906 | 789.00K |
| 388 | ACET | Adicet Bio, Inc. | 75.09M | 5.54% | 66,122 | - |
| 389 | XBIT | XBiotech Inc. | 75.00M | 5.12% | 816 | - |
| 390 | NRXS | NeurAxis, Inc. | 73.50M | 6.48% | 252,738 | 3.36M |
| 391 | IMA | ImageneBio, Inc. | 71.56M | 6.67% | 14,590 | 800.00K |
| 392 | BYSI | BeyondSpring Inc. | 70.32M | 4.91% | 24,047 | 1.88M |
| 393 | LONA | LeonaBio, Inc. | 69.09M | -1.33% | 7,787 | - |
| 394 | GUTS | Fractyl Health, Inc. | 69.06M | -4.09% | 594,146 | 3.00K |
| 395 | COEP | Coeptis Therapeutics Holdings, Inc. | 68.73M | 0.25% | 17,505 | 501.00K |
| 396 | IFRX | InflaRx N.V. | 68.42M | 2.97% | 112,533 | 73.73K |
| 397 | MNOV | MediciNova, Inc. | 67.45M | -0.70% | 740 | 409.66K |
| 398 | ANVS | Annovis Bio, Inc. | 65.99M | 1.22% | 113,144 | - |
| 399 | GRCE | Grace Therapeutics, Inc. | 63.44M | 0.99% | 161,591 | - |
| 400 | MREO | Mereo BioPharma Group plc | 63.33M | 2.87% | 815,331 | 500.00K |
| 401 | TCRX | TScan Therapeutics, Inc. | 62.59M | -2.65% | 187,040 | 10.33M |
| 402 | ENTX | Entera Bio Ltd. | 62.37M | 3.03% | 8,377 | 124.00K |
| 403 | ATHE | Alterity Therapeutics Limited | 61.71M | -2.20% | 351 | 4.43M |
| 404 | EXOZ | eXoZymes, Inc. | 61.32M | 1.25% | 119 | -700.00 |
| 405 | LPCN | Lipocine Inc. | 58.84M | 0.12% | 47,017 | 1.98M |
| 406 | ICCC | ImmuCell Corporation | 58.80M | -1.96% | 12,173 | 27.64M |
| 407 | HYFT | MindWalk Holdings Corp. | 58.60M | -4.20% | 177,484 | 18.18M |
| 408 | ACTU | Actuate Therapeutics, Inc. | 58.57M | -1.18% | 43,477 | - |
| 409 | NRXP | NRx Pharmaceuticals, Inc. | 58.33M | 1.67% | 127,016 | 242.00K |
| 410 | MGX | Metagenomi Therapeutics, Inc. | 58.31M | -1.27% | 78,669 | 25.21M |
| 411 | TIL | Instil Bio, Inc. | 56.36M | -5.03% | 32,284 | - |
| 412 | IBO | Impact BioMedical Inc. | 55.47M | -8.14% | 174,535 | 32.00K |
| 413 | RADX | Radiopharm Theranostics Limited | 55.30M | -2.25% | 8,181 | 10.86M |
| 414 | OSTX | OS Therapies Incorporated | 54.23M | 1.32% | 111,449 | - |
| 415 | ESLA | Estrella Immunopharma, Inc. | 53.38M | 1.60% | 7,993 | - |
| 416 | KZR | Kezar Life Sciences, Inc. | 52.10M | -0.91% | 4,579 | - |
| 417 | EDSA | Edesa Biotech, Inc. | 51.76M | -2.82% | 212,507 | - |
| 418 | ACRV | Acrivon Therapeutics, Inc. | 51.59M | 1.55% | 58,923 | - |
| 419 | RLYB | Rallybio Corporation | 50.83M | 0.10% | 49,825 | 674.00K |
| 420 | OKUR | OnKure Therapeutics, Inc. | 50.13M | 5.11% | 50,363 | - |
| 421 | NXTC | NextCure, Inc. | 48.87M | 1.52% | 12,432 | - |
| 422 | NTRB | Nutriband Inc. | 48.75M | 5.25% | 1,830 | 2.28M |
| 423 | PSTV | Plus Therapeutics, Inc. | 48.29M | -7.36% | 2,460,504 | 5.21M |
| 424 | ALGS | Aligos Therapeutics, Inc. | 47.58M | 3.78% | 8,323 | 2.19M |
| 425 | IMMP | Immutep Limited | 47.04M | -81.00% | 30,893,662 | 5.28M |
| 426 | ATRA | Atara Biotherapeutics, Inc. | 46.87M | -5.80% | 67,416 | 151.93M |
| 427 | TELO | Telomir Pharmaceuticals, Inc. | 46.76M | -2.86% | 14,977 | - |
| 428 | INKT | MiNK Therapeutics, Inc. | 45.77M | -5.16% | 57,425 | - |
| 429 | LSTA | Lisata Therapeutics, Inc. | 44.32M | -0.11% | 16,570 | 170.00K |
| 430 | ATOS | Atossa Therapeutics, Inc. | 44.18M | 1.58% | 16,745 | - |
| 431 | LITS | Lite Strategy, Inc. | 43.63M | 4.35% | 87,551 | - |
| 432 | APLM | Apollomics, Inc. | 42.73M | 0.51% | 259 | 6.93M |
| 433 | HOWL | Werewolf Therapeutics, Inc. | 41.28M | 2.97% | 138,004 | 1.14M |
| 434 | CRVO | CervoMed Inc. | 40.76M | 1.73% | 18,411 | 6.16M |
| 435 | PTN | Palatin Technologies, Inc. | 40.74M | 3.87% | 7,241 | 8.96M |
| 436 | SNSE | Sensei Biotherapeutics, Inc. | 39.67M | 0.48% | 60,353 | - |
| 437 | VERU | Veru Inc. | 38.68M | -2.03% | 7,360 | 16.89M |
| 438 | XLO | Xilio Therapeutics, Inc. | 38.21M | 1.74% | 127,691 | 31.80M |
| 439 | EVAX | Evaxion A/S | 37.36M | 7.18% | 52,702 | 7.53M |
| 440 | CELU | Celularity Inc. | 36.05M | -1.57% | 31,383 | 40.58M |
| 441 | PDSB | PDS Biotechnology Corporation | 35.56M | -0.64% | 37,841 | - |
| 442 | TVRD | Tvardi Therapeutics, Inc. | 35.37M | 2.59% | 13,036 | - |
| 443 | INMB | INmune Bio Inc. | 35.36M | - | 64,935 | 50.00K |
| 444 | ATNM | Actinium Pharmaceuticals, Inc. | 34.94M | -0.88% | 65,760 | 90.00K |
| 445 | JSPR | Jasper Therapeutics, Inc. | 34.14M | -3.94% | 199,916 | - |
| 446 | RNTX | Rein Therapeutics Inc. | 33.91M | 0.78% | 4,350 | - |
| 447 | PLUR | Pluri Inc. | 33.77M | 4.02% | 936 | 1.34M |
| 448 | OTLK | Outlook Therapeutics, Inc. | 33.64M | -3.80% | 415,201 | 205.70K |
| 449 | ABVC | ABVC BioPharma, Inc. | 32.12M | -5.11% | 26,845 | 797.92K |
| 450 | NBY | NovaBay Pharmaceuticals, Inc. | 31.61M | -4.72% | 60,590 | 10.30M |
| 451 | RNXT | RenovoRx, Inc. | 31.21M | 5.38% | 137,912 | 928.00K |
| 452 | TPST | Tempest Therapeutics, Inc. | 30.87M | - | 21,155 | - |
| 453 | BCTX | BriaCell Therapeutics Corp. | 30.50M | 0.23% | 83,493 | - |
| 454 | HYPD | Hyperion DeFi, Inc. | 29.73M | 4.12% | 168,384 | 345.32K |
| 455 | AEON | AEON Biopharma, Inc. | 29.60M | - | 36,040 | - |
| 456 | CVM | CEL-SCI Corporation | 28.73M | 0.85% | 14,863 | - |
| 457 | NRSN | NeuroSense Therapeutics Ltd. | 28.72M | 1.18% | 16,322 | - |
| 458 | KYNB | Kyntra Bio, Inc. | 28.52M | 0.43% | 12,319 | 8.30M |
| 459 | DYAI | Dyadic International, Inc. | 28.51M | 3.06% | 5,952 | 3.34M |
| 460 | LTRN | Lantern Pharma Inc. | 28.18M | -0.40% | 2,187 | - |
| 461 | IGC | IGC Pharma, Inc. | 27.84M | 2.62% | 251,108 | 1.11M |
| 462 | CUE | Cue Biopharma, Inc. | 27.29M | -7.96% | 559,650 | 7.10M |
| 463 | LIXT | Lixte Biotechnology Holdings, Inc. | 26.75M | -5.25% | 3,749 | - |
| 464 | TVGN | Tevogen Bio Holdings Inc. | 26.11M | 1.10% | 621 | - |
| 465 | XCUR | Exicure, Inc. | 25.94M | 3.30% | 3,997 | 500.00K |
| 466 | BOLD | Boundless Bio, Inc. | 25.54M | 1.79% | 12,120 | - |
| 467 | NEUP | Neuphoria Therapeutics Inc. | 25.07M | -1.69% | 15,143 | 14.99M |
| 468 | SNTI | Senti Biosciences, Inc. | 25.02M | -4.39% | 70,723 | - |
| 469 | BRNS | Barinthus Biotherapeutics plc | 24.70M | 0.83% | 4,484 | 14.97M |
| 470 | PASG | Passage Bio, Inc. | 24.70M | -4.94% | 17,553 | - |
| 471 | VTGN | Vistagen Therapeutics, Inc. | 24.14M | -3.42% | 130,845 | 789.00K |
| 472 | NNVC | NanoViricides, Inc. | 23.97M | -4.31% | 168,563 | - |
| 473 | PLRZ | Polyrizon Ltd. | 23.59M | -3.20% | 10,895 | - |
| 474 | MRKR | Marker Therapeutics, Inc. | 22.76M | 1.11% | 25,995 | 4.69M |
| 475 | SKYE | Skye Bioscience, Inc. | 22.70M | -3.80% | 162,769 | - |
| 476 | CTXR | Citius Pharmaceuticals, Inc. | 21.61M | 11.34% | 618,293 | 3.94M |
| 477 | DARE | Daré Bioscience, Inc. | 21.21M | 0.27% | 10,594 | -57.13K |
| 478 | ALLR | Allarity Therapeutics, Inc. | 21.07M | -2.96% | 58,753 | - |
| 479 | FBLG | FibroBiologics, Inc. | 21.06M | -8.38% | 393,330 | - |
| 480 | LGVN | Longeveron Inc. | 20.39M | 18.13% | 8,336,865 | 1.44M |
| 481 | GNTA | Genenta Science S.p.A. | 19.92M | -1.73% | 3,357 | - |
| 482 | VYNE | VYNE Therapeutics Inc. | 19.66M | 0.44% | 46,947 | 570.00K |
| 483 | KTTA | Pasithea Therapeutics Corp. | 18.73M | -1.96% | 5,819 | - |
| 484 | INTS | Intensity Therapeutics, Inc. | 18.50M | -1.62% | 3,603 | - |
| 485 | INAB | IN8bio, Inc. | 18.46M | -1.05% | 23,476 | - |
| 486 | CVKD | Cadrenal Therapeutics, Inc. | 17.61M | 4.87% | 17,740 | - |
| 487 | LEXX | Lexaria Bioscience Corp. | 17.15M | 1.50% | 36,119 | 522.00K |
| 488 | HOTH | Hoth Therapeutics, Inc. | 16.60M | - | 113,675 | - |
| 489 | TRAW | Traws Pharma, Inc. | 16.54M | 2.48% | 111,002 | 2.85M |
| 490 | SER | Serina Therapeutics, Inc. | 16.50M | -1.92% | 23,917 | 116.00K |
| 491 | IOBT | IO Biotech, Inc. | 15.83M | -0.81% | 569,675 | - |
| 492 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 15.19M | -1.89% | 58,190 | - |
| 493 | PHIO | Phio Pharmaceuticals Corp. | 14.41M | -0.80% | 126,404 | - |
| 494 | CLRB | Cellectar Biosciences, Inc. | 14.12M | 3.10% | 30,364 | - |
| 495 | COCP | Cocrystal Pharma, Inc. | 14.06M | 0.99% | 4,634 | - |
| 496 | BCDA | BioCardia, Inc. | 13.80M | 2.36% | 9,103 | 3.00K |
| 497 | JUNS | Jupiter Neurosciences, Inc. | 13.77M | 8.55% | 142,134 | - |
| 498 | CRIS | Curis, Inc. | 13.56M | -1.98% | 21,834 | 11.65M |
| 499 | BCAB | BioAtla, Inc. | 13.53M | -0.95% | 442,829 | 11.00M |
| 500 | QNRX | Quoin Pharmaceuticals, Ltd. | 13.30M | -2.35% | 2,850 | - |
| 501 | GTBP | GT Biopharma, Inc. | 13.30M | -0.85% | 140,161 | - |
| 502 | NCEL | NewcelX Ltd. | 12.56M | -1.25% | 761 | - |
| 503 | SNGX | Soligenix, Inc. | 12.56M | 2.05% | 104,294 | 2.34K |
| 504 | KAPA | Kairos Pharma, Ltd. | 12.51M | 0.13% | 28,373 | - |
| 505 | BLRX | BioLineRx Ltd. | 12.50M | 0.94% | 1,461 | 12.74M |
| 506 | OSRH | OSR Holdings, Inc. | 12.20M | -4.94% | 247,079 | -90.52K |
| 507 | CALC | CalciMedica, Inc. | 11.98M | 4.83% | 274,457 | - |
| 508 | GDTC | CytoMed Therapeutics Limited | 11.66M | -5.59% | 2,399 | 573.19K |
| 509 | AKTX | Akari Therapeutics, Plc | 11.53M | -0.74% | 446,582 | - |
| 510 | CMMB | Chemomab Therapeutics Ltd. | 11.33M | -1.07% | 2,481 | - |
| 511 | ACXP | Acurx Pharmaceuticals, Inc. | 10.95M | -14.17% | 4,321,224 | - |
| 512 | IMNN | Imunon, Inc. | 10.95M | 2.54% | 4,884 | - |
| 513 | BIVI | BioVie Inc. | 10.56M | 0.73% | 9,326 | - |
| 514 | LIMN | Liminatus Pharma, Inc. | 10.55M | -1.22% | 858,036 | - |
| 515 | MBRX | Moleculin Biotech, Inc. | 10.11M | - | 47,475 | - |
| 516 | QNTM | Quantum BioPharma Ltd. | 9.85M | -0.02% | 144,624 | - |
| 517 | PHGE | BiomX Inc. | 9.56M | -5.81% | 44,929 | - |
| 518 | ICU | SeaStar Medical Holding Corporation | 9.37M | -1.52% | 30,442 | 881.00K |
| 519 | ERNA | Ernexa Therapeutics Inc. | 9.26M | 10.65% | 1,597,385 | 1,000.00 |
| 520 | ITRM | Iterum Therapeutics plc | 9.01M | -0.29% | 134,872 | 390.00K |
| 521 | CLGN | CollPlant Biotechnologies Ltd. | 8.86M | 3.89% | 11,874 | 2.48M |
| 522 | RNAZ | TransCode Therapeutics, Inc. | 8.76M | -2.55% | 1,499 | - |
| 523 | NCNA | NuCana plc | 8.24M | -0.50% | 18,875 | - |
| 524 | TOVX | Theriva Biologics, Inc. | 8.12M | -2.15% | 505,967 | - |
| 525 | BOLT | Bolt Biotherapeutics, Inc. | 8.00M | 2.96% | 5,606 | 7.70M |
| 526 | ALZN | Alzamend Neuro, Inc. | 7.88M | -0.96% | 14,267 | - |
| 527 | PULM | Pulmatrix, Inc. | 7.74M | -1.85% | 4,208 | 3.00K |
| 528 | KPRX | Kiora Pharmaceuticals, Inc. | 7.59M | -3.72% | 7,530 | 20.00K |
| 529 | KALA | KALA BIO, Inc. | 7.54M | -10.04% | 6,803,683 | - |
| 530 | MLEC | Moolec Science SA | 7.53M | -9.17% | 13,289 | 7.83M |
| 531 | PMCB | PharmaCyte Biotech, Inc. | 7.50M | 0.55% | 1,390 | - |
| 532 | GRDX | GridAI Technologies Corp. | 7.50M | 1.36% | 9,433 | - |
| 533 | IMRN | Immuron Limited | 7.18M | 6.78% | 3,114 | 4.99M |
| 534 | CDIO | Cardio Diagnostics Holdings, Inc. | 7.14M | -14.25% | 244,475 | 15.78K |
| 535 | EVGN | Evogene Ltd. | 7.13M | -3.58% | 105,083 | 3.85M |
| 536 | MBIO | Mustang Bio, Inc. | 6.97M | 1.08% | 7,732 | - |
| 537 | TCRT | Alaunos Therapeutics, Inc. | 6.96M | -2.19% | 10,550 | 6.00K |
| 538 | PCSA | Processa Pharmaceuticals, Inc. | 6.80M | 8.70% | 23,752 | - |
| 539 | CELZ | Creative Medical Technology Holdings, Inc. | 6.67M | -1.55% | 12,622 | 6.00K |
| 540 | ADXN | Addex Therapeutics Ltd | 6.63M | -4.80% | 144 | 198.82K |
| 541 | APM | Aptorum Group Limited | 6.44M | -1.15% | 1,623 | - |
| 542 | XTLB | XTL Biopharmaceuticals Ltd. | 6.34M | 2.86% | 1,419 | 968.00K |
| 543 | XBIO | Xenetic Biosciences, Inc. | 6.21M | 5.65% | 27,490 | 2.98M |
| 544 | BRTX | BioRestorative Therapies, Inc. | 6.11M | -7.47% | 1,150,299 | 383.40K |
| 545 | PPBT | Purple Biotech Ltd | 5.98M | 3.39% | 9,186 | - |
| 546 | ASBP | Aspire Biopharma Holdings, Inc. | 5.80M | 2.69% | 37,103 | 1.94K |
| 547 | QNCX | Quince Therapeutics, Inc. | 5.69M | -4.13% | 9,907,039 | - |
| 548 | PBM | Psyence Biomedical Ltd. | 5.62M | -0.41% | 732 | - |
| 549 | CYCN | Cyclerion Therapeutics, Inc. | 5.56M | 2.82% | 2,792 | 2.86M |
| 550 | MTVA | MetaVia Inc. | 5.27M | 2.11% | 13,945 | - |
| 551 | APRE | Aprea Therapeutics, Inc. | 5.25M | -1.93% | 4,477 | 488.24K |
| 552 | SLXN | Silexion Therapeutics Corp | 5.22M | 0.22% | 14,122 | - |
| 553 | CANF | Can-Fite BioPharma Ltd. | 5.17M | -1.88% | 22,578 | 560.00K |
| 554 | GOVX | GeoVax Labs, Inc. | 4.83M | -1.08% | 3,936 | 3.35M |
| 555 | VIVS | VivoSim Labs, Inc. | 4.80M | -1.08% | 15,264 | 142.00K |
| 556 | REVB | Revelation Biosciences, Inc. | 4.72M | 3.24% | 12,556 | - |
| 557 | GNPX | Genprex, Inc. | 4.48M | -1.53% | 51,000 | - |
| 558 | APVO | Aptevo Therapeutics Inc. | 4.41M | -3.28% | 14,451 | - |
| 559 | SILO | Silo Pharma, Inc. | 4.40M | -3.85% | 45,917 | 72.10K |
| 560 | LNAI | Lunai Bioworks Inc. | 4.26M | -8.38% | 594,204 | - |
| 561 | GLMD | Galmed Pharmaceuticals Ltd. | 4.20M | -1.97% | 1,632 | - |
| 562 | MTNB | Matinas BioPharma Holdings, Inc. | 4.16M | 1.85% | 3,896 | - |
| 563 | DCOY | Decoy Therapeutics Inc. | 4.10M | 2.94% | 6,725 | - |
| 564 | GRI | GRI Bio, Inc. | 4.06M | -3.77% | 7,701 | - |
| 565 | INDP | Indaptus Therapeutics, Inc. | 4.04M | - | 9,377 | - |
| 566 | BGMS | Bio Green Med Solution, Inc. | 3.97M | -14.54% | 214,311 | 81.00K |
| 567 | OGEN | Oragenics, Inc. | 3.78M | -7.65% | 249,148 | - |
| 568 | XRTX | XORTX Therapeutics Inc. | 3.27M | -11.11% | 47,593 | - |
| 569 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 3.22M | -13.92% | 388,419 | 1.36M |
| 570 | HCWB | HCW Biologics Inc. | 3.10M | -3.60% | 6,074 | 422.03K |
| 571 | DRMA | Dermata Therapeutics, Inc. | 2.94M | -0.81% | 38,282 | - |
| 572 | AZTR | Azitra, Inc. | 2.78M | -4.67% | 325,362 | 7.50K |
| 573 | ARTL | Artelo Biosciences, Inc. | 2.75M | -0.51% | 8,780 | - |
| 574 | ADIL | Adial Pharmaceuticals, Inc. | 2.68M | 0.27% | 8,962 | - |
| 575 | ENVB | Enveric Biosciences, Inc. | 2.64M | -1.02% | 14,218 | - |
| 576 | CDT | CDT Equity Inc. | 2.55M | -2.07% | 16,612 | - |
| 577 | SCNI | Scinai Immunotherapeutics Ltd. | 2.53M | - | 1,349 | 1.15M |
| 578 | ELAB | PMGC Holdings Inc. | 2.51M | 5.45% | 28,834 | 285.95K |
| 579 | JAGX | Jaguar Health, Inc. | 2.46M | -0.73% | 77,888 | 11.79M |
| 580 | CLDI | Calidi Biotherapeutics, Inc. | 2.40M | -1.27% | 126,353 | - |
| 581 | SPRC | SciSparc Ltd. | 2.36M | -11.63% | 23,214 | 1.31M |
| 582 | LYRA | Lyra Therapeutics, Inc. | 2.34M | -1.49% | 2,014 | 600.00K |
| 583 | BBLG | Bone Biologics Corporation | 2.26M | -0.14% | 2,104 | - |
| 584 | PPCB | Propanc Biopharma, Inc. | 1.87M | -2.40% | 1,653,175 | - |
| 585 | ENSC | Ensysce Biosciences, Inc. | 1.67M | 5.69% | 120,877 | 4.49M |
| 586 | CNSP | CNS Pharmaceuticals, Inc. | 1.62M | -8.10% | 131,070 | - |
| 587 | VRAX | Virax Biolabs Group Limited | 1.49M | 2.60% | 13,973 | 2.99K |
| 588 | CMND | Clearmind Medicine Inc. | 1.47M | -1.05% | 96,157 | - |
| 589 | ONCO | Onconetix, Inc. | 889.94K | -0.07% | 7,267 | 1.22M |
| 590 | BDRX | Biodexa Pharmaceuticals Plc | 712.97K | -1.95% | 14,830 | 104.90K |
| 591 | ADTX | Aditxt, Inc. | 409.59K | -36.16% | 922,912 | 5.95K |